HEAL.L
iShares Healthcare Innovation UCITS ETF
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.5 B
ASSETS UNDER MGMT
40 bp
EXPENSES
Fund Basics
| Inception date | Sep 08, 2016 |
| Regulation | UCITS |
| ISIN | IE00BYZK4776 |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ILLUMINA INC | 2.4 % |
| EXACT SCIENCES CORP | 2.1 % |
| UCB SA | 2.1 % |
| MODERNA, INC. | 2.1 % |
| THERMO FISHER SCIENTIFIC INC | 2.1 % |
| IQVIA HOLDINGS INC | 2.1 % |
| NATERA INC | 2.0 % |
| GENMAB A/S | 2.0 % |
| JOHNSON & JOHNSON | 1.9 % |
| MERCK & CO. INC. | 1.9 % |
Constituent Breakdown
| Number of holdings | 213 |
| Herfindahl-Hirschman Index | 127 |
| Wgt avg mkt cap (mns) | $64,658 |
| Large cap (>$10bn) | 65.9% |
| Mid cap ($2-10bn) | 21.1% |
| Small cap (<$2bn) | 7.1% |
| Developed mkts. | 88.2% |
| Emerging mkts. | 6.7% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 65.6 % |
 |
SWITZERLAND | 5.4 % |
 |
SOUTH KOREA | 4.3 % |
 |
JAPAN | 3.5 % |
 |
DENMARK | 2.4 % |
 |
CHINA | 2.4 % |
 |
BELGIUM | 2.3 % |
 |
IRELAND | 2.2 % |
 |
BRITAIN | 2.1 % |
 |
FRANCE | 1.4 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 2.2% | 19.7% | 10.1% | 8.1% | -2.0% | -- | -- | 6.9% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | 0.0% |
| Total Returns | 2.2% | 19.7% | 10.1% | 8.1% | -2.0% | -- | -- | 6.9% | Ann. Volatility | 16.6% | 18.8% | 16.9% | 16.7% | 20.0% | -- | -- | 19.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.08 | 1% |
| MSCI EAFE | 0.26 | 5% |
| MSCI Emg Mkts | 0.26 | 6% |
Liquidity Measures
| Avg. volume (000) | 98 |
| ADV traded (mns) | $1 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $9.19 |
| Relative strength (RSI) | 52 |
| MACD/Signal | -0.03/-0.03 |
| Bollinger Bands (Upper/Lower) | $9.35/$8.99 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HEAL.L |
Expenses vs. HEAL.L |
ALTAR Score™ vs. HEAL.L |
|---|---|---|---|---|
| WHCS.AS | iShares MSCI World Health Care Sector Advanced UCITS ETF | 29.8% | -22 bp | +4.1% |
| WHCA.L | iShares MSCI World Health Care Sector Advanced UCITS ETF | 29.8% | -22 bp | +3.8% |
| XDWH.DE | Xtrackers MSCI World Health Care UCITS ETF 1C | 28.8% | -15 bp | +4.2% |
| XGEN.DE | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 28.0% | -10 bp | -2.2% |
| XDG3.DE | Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 27.4% | -5 bp | +3.6% |
| WELS.DE | Amundi S&P World Health Care Screened UCITS ETF Acc | 26.2% | -22 bp | +4.1% |
| WELG.DE | Amundi S&P World Health Care Screened UCITS ETF Dist | 26.2% | -22 bp | +4.0% |
| XUHC.DE | Xtrackers MSCI USA Health Care UCITS ETF 1D | 25.5% | -28 bp | +4.3% |
| XUHL.DE | Xtrackers MSCI USA Health Care UCITS ETF 1C | 25.5% | -28 bp | +4.0% |
| IUHE.AS | iShares S&P 500 Health Care Sector UCITS ETF | 25.3% | -22 bp | +4.6% |
Risk and Returns: HEAL.L vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.5%
ALTAR SCORE™
22nd
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 579 funds in the Global Equity category with an average
ALTAR Score™ of 4.6% and a standard deviation
of 2.7%. HEAL.L's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places HEAL.L in the 22nd percentile
among funds in the category.
Sell-Side Consensus
$10.91
PRICE TARGET
+24.6%
UPSIDE